Generation of fluorescent and bioluminescent induced pluripotent stem cells with their application in tracking organoid development
Authors:
- 9 August 2025
- journal article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 69, 102849
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (32371426)
- Natural Science Foundation of Tianjin Municipality (24JCZDJC01380)
- Natural Science Foundation of Tianjin Municipality (NKTM2023005)
- National Key Research and Development Program of China
- National Key Research and Development Program of China Stem Cell and Translational Research (2020YFA0803700)
This publication has 38 references indexed in Scilit:
- Pancreatic β-cell remodeling in health and aging: Lessons from rodents and humansAgeing Research Reviews, 2025
- Tracking induced pluripotent stem cell differentiation with a fluorescent genetically encoded epigenetic probeCellular and Molecular Life Sciences, 2024
- Bioengineering and vascularization strategies for islet organoids: advancing toward diabetes therapyMetabolism, 2024
- Recent advances in endocrine organoids for therapeutic applicationAdvanced Drug Delivery Reviews, 2023
- Type 1 diabetes and engineering enhanced islet transplantationAdvanced Drug Delivery Reviews, 2022
- Delivery of therapeutic agents and cells to pancreatic islets: Towards a new era in the treatment of diabetesMolecular Aspects of Medicine, 2022
- Tools for Bioimaging Pancreatic β Cells in DiabetesTrends in Molecular Medicine, 2019
- Navigating Two Roads to Glucose Normalization in Diabetes: Automated Insulin Delivery Devices and Cell TherapyCell Metabolism, 2019
- Molecular imaging of β-cells: diabetes and beyondAdvanced Drug Delivery Reviews, 2019
- Radionuclide probes for molecular imaging of pancreatic beta-cellsAdvanced Drug Delivery Reviews, 2010